Voloridge Investment Management, LLC Royalty Pharma PLC Transaction History

Voloridge Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$26.21 - $29.22 $1.27 Million - $1.42 Million	-48,583 Reduced 66.45%	24,524 $688,000
Q3 2023 Nov 14, 2023	SELL	$26.26 - $31.38 $8.13 Million - $9.72 Million	-309,622 Reduced 80.9%	73,107 $1.98 Million
Q2 2023 Aug 14, 2023	SELL	$29.6 - $36.56 $1.64 Million - $2.02 Million	-55,272 Reduced 12.62%	382,729 $11.8 Million
Q1 2023 May 15, 2023	SELL	$32.77 - $39.4 $369,973 - $444,826	-11,290 Reduced 2.51%	438,001 $15.8 Million
Q4 2022 Feb 14, 2023	BUY	$39.17 - $44.04 $17.6 Million - $19.8 Million	449,291 New	449,291 $17.8 Million
Q4 2021 Feb 14, 2022	SELL	$35.17 - $42.48 $393,728 - $475,563	-11,195 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$36.14 - $42.24 $2.12 Million - $2.48 Million	-58,710 Reduced 83.99%	11,195 $405,000
Q2 2021 Aug 16, 2021	BUY	$39.85 - $46.63 $2.79 Million - $3.26 Million	69,905 New	69,905 $2.87 Million

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.